Biotech

All Articles

Analysts go into Avidity's DMD win, showing distinctions in records

.Avidity Biosciences satisfied capitalists along with phase 1/2 data in Duchenne muscle dystrophy (D...

Actinogen's cortisol blocker neglects period 2 anxiety research study

.Actinogen Medical's cortisol blocker has overlooked the major endpoint of a period 2 study in depre...

Bivictrix chooses going personal only way to take ADC right into clinic

.Antibody-drug conjugates (ADCs) have been at the center of many a billion-dollar biobuck licensing ...

TPG leadings up funds to $580M for investments all over lifestyle scientific researches

.Resource manager TPG, which has actually assisted biotechs like Sionna Therapeutics and Santa Clam ...

Merck stops period 3 TIGIT test in lung cancer for impossibility

.Merck &amp Co.'s TIGIT program has gone through yet another trouble. Months after shuttering a peri...

After a hard year, Exscientia folds up right into Recursion

.After a year described through pipeline cuts, the departure of its own chief executive officer and ...

Cullinan, after $25M package, hands back bispecific to Port

.Cullinan Therapy was actually excited good enough with Harbour BioMed's bispecific immune activator...

A nearer examine Fierce Biotech's Fierce 15

.In this particular week's incident of "The Best Line," our experts are actually diving into Ferocio...

Lilly deals with stage 2 failure of tau-targeting med

.The confetti is actually still flying from Eli Lilly's gathering commemorating the commendation of ...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of significant management hirings, firings as...